Pacific Biosciences of California, Inc.
PACBStock
$1.49+6.25%52W
Market Cap$475.22M
P/E—
Div yield—
Beta2.34
Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-37.63%
Price vs S&P 500 (4W)12.74%
VGM Score43.81
Market Capitalization$475.22M
Earnings Surprise History
Q1 26-0.12est. -0.14
Analyst Recommendations
Apr 2026
May 2026
Jun 2026
Jul 2026
3.75
3.75
3.80
3.86
Industry Peers — Lab Analytical Instruments(24)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
PACBPacific Biosciences of California, Inc. | D | C | C | $1.49 |
| AAgilent Technologies Inc. | C | C | B | $136.10 |
| WATWaters Corp | D | C | B | $378.19 |
| ILMNIllumina Inc | D | D | A | $190.25 |
| MTDMettler-Toledo International | D | C | C | $1335.09 |
| RVTYRevvity, Inc. | C | D | B | $111.70 |
| BRKRBruker Corporation | D | D | B | $59.25 |
| BIOBio-Rad Laboratories, Inc.Class A | C | F | B | $300.98 |
| BIO.BBio-Rad Laboratories, Inc. Class B | C | F | B | $309.37 |
| AVTRAvantor, Inc. | B | F | B | $11.26 |
| TXG10x Genomics, Inc. Class A Common Stock | F | C | A | $44.48 |
About
Pacific Biosciences develops and manufactures DNA sequencing platforms that enable genetic analysis for research and clinical applications. The company's integrated technology helps scientists and clinical researchers identify and resolve complex genetic problems. Revenue is generated primarily from the Americas, with significant contributions from Europe, the Middle East, Africa, and Asia-Pacific.